Company / Income Tax
Amylyx Pharmaceuticals, Inc. Income Tax History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$46.0K
FY2025
5-year range
-$393.0K / $5.0M
FY2022-FY2025
Trend
+111.7%
vs FY2024
Sector context
#107 of 204
Health Care
What the data says
At $46,000, Amylyx Pharmaceuticals, Inc.'s income tax ranks #98 of 204 in the Health Care sector. Improved from $5M to $46,000 over the past 2 years.
Based on SEC 10-K filings.
$46,000 in FY2025 with a 3-year CAGR of -61.0%.
Improved from $5M to $46,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -61.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#98 of 204 in Health CareTop 48% of 204This company $46.0K Sector average $118.7M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -61.0%, indicating a declining trend.
- In FY2025, income tax increased 111.7% year-over-year.
- Ranks #107 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.0K | +111.7% |
| FY2024 | -$393.0K | -107.8% |
| FY2023 | $5.0M | +549.4% |
| FY2022 | $774.0K | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026